Pharma and Biotech
| Competitors: | Hemogenyx Pharmaceuticals |
| Executive Director: | Daniel Gooding |
| Independent Non-Executive Director: | Madeleine Kennedy |
| Non-Executive Chairman: | Julian Gilbert |
| Non-Executive Dir: |
| Address: | C/O Arch Law Limited, Huckletree Bishopsgate, 8 Bishopsgate, London, United Kingdom, EC2N 4BQ |
| Phone: | +44 (0)1223 627222 |
| Website: | https://nuformix.com/ |
| Sector: | Pharma and Biotech(LSE) |
| ISIN: | GB00BYW79Y38 |
| Currency | UK Pounds |
| Share Price | 0.25p |
| Change Today | 0.005p |
| % Change | -1.96 % |
| 52 Week High | 0.49 |
| 52 Week Low | 0.047 |
| Volume | 5,704,930 |
| Shares Issued | 2,109.75m |
| Market Cap | £5.27m |
| RiskGrade | 322 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:35 | 7,899 @ 0.24p |
| 16:35 | 3,760 @ 0.26p |
| 16:35 | 3,422 @ 0.24p |
| 16:35 | 50,713 @ 0.24p |
| 16:35 | 80,496 @ 0.24p |
You are here: research